ZERO believes collaboration is key to translational research and is constantly seeking new opportunities to collaborate nationally and internationally.
The ZERO Program has developed extensive clinical and research collaborations from around the country. The national clinical trial has been pivotal in unifying national efforts toward identifying possible treatment options for children with high-risk cancer and improving quality of life.
As the Program looks to expand to reach all children with cancer in Australia by 2023, new collaboration opportunities will inevitably appear ranging from fundamental biology to pharmaceutical development to genomic profiling.
ZERO is committed to contributing to the research and clinical community through opportunities to share the rich and unique sample and data sets via direct research and industry collaborations, and independent ethics approved research through a formal sample and data access application program, in addition to ZERO’s existing research projects.
For general enquiries about collaboration opportunities, please contact email@example.com.